Compare Johnson & Johnson (JNJ) vs Northrop Grumman Corporation (NOC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Northrop Grumman Corporation — how do they compare? Johnson & Johnson trades at $261.44 (market cap $618.09B), while Northrop Grumman Corporation trades at $480.72 (market cap $68.83B). The key difference: Johnson & Johnson is far larger — about 9× Northrop Grumman Corporation's market cap, and Johnson & Johnson pays the higher dividend (2.09%). Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and Northrop Grumman Corporation for 81 Days on average.
| JNJ | NOC | |
|---|---|---|
Market Cap | $618.09B | $68.83B |
Volume | 6,050,983 | 1,081,989 |
Sector | Health | Industrials |
52-Week High | $278.43 | $768.02 |
52-Week Low | $186.00 | $473.46 |
Typical Hold Time | 129 Days | 81 Days |
Enterprise Value | $646.37B | $82.81B |
Dividend Yield | 2.09% | 2.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $256.48, down 0.76% on the day, with the stock showing mixed technical signals amid a bearish overall trend. The company maintains strong fundamentals with $94.19B in 2025 revenue, 21.48% net income margin, and consistent earnings beats in recent quarters. Recent analyst coverage shows 52.5% buy ratings with a $286.53 consensus price target, while technical indicators point to key support at $248 and resistance at $258.
JNJ presents a compelling long-term investment case with robust profitability, diversified healthcare portfolio, and dividend stability, though near-term headwinds include patent expirations and competitive pressures. The stock's current valuation at 29.75 P/E appears reasonable given strong cash flow generation and pipeline innovation, with upside potential to analyst targets if execution continues.
Northrop Grumman (NOC) trades at $484.48, up 2.33% on the day, but technical indicators signal a bearish trend. The company demonstrates strong fundamentals with consistent earnings beats, a net income margin of 10.48%, and a robust backlog. Recent news highlights a competitive setback with Boeing winning a major Navy contract, though the company maintains solid defense sector positioning.
The outlook is mixed; strong profitability and analyst buy ratings support upside to a $600.62 consensus target, but near-term technical pressure and contract loss risks pose challenges. Revenue growth and dividend stability offer investor appeal, though sector volatility and execution risks require monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Northrop Grumman Corporation
Northrop Grumman is a defense contractor that is diversified across short-cycle and long-cycle businesses. The firm's segments include aeronautics, mission systems, defense services, and space systems. The company's aerospace segment creates the fuselage for the massive F-35 program and produces various piloted and autonomous flight systems. Mission systems creates a variety of sensors and processors for defense hardware. The defense systems segment is a long-range missile manufacturer. Finally, the company's space systems segment produces various space structures, sensors, and satellites.
Read more on NOC →
